Nationwide alert in China for the faulty rabies vaccine

The second largest drug manufacturing company “ Changchun Changsheng Life Sciences” were found guilty for violated national standards including usage of expired fluids and falsified production dates to produce rabies vaccine. Rabies Vaccines manufactured in China was widely exported to countries including India too.

This recent scandal of faulty Rabies Vaccines creating panic and especially in China. After taking a quick action on this, country has started a nationwide campaign to provide health consultation and free inoculation of rabies vaccines.

In India, the Drug Controller General of India also ordered immediately to withdraw rabies vaccines from the market and also banned their imports from Changchun Changsheng Life Sciences.

Healthcare centers, institutions and disease control centers have started providing consultation services for those who received or used rabies vaccines made by the company. 36,482 hospitals and health centers are designated by the China government to provide consultation. No life loss has been reported yet from the patients who injected with the faulty Rabies vaccines.

According to the report, Changchun Changsheng making use of expired fluids and false production dates is in continuity since April 2014 and had violated rules on production management and national drug standards for the vaccines.

China National Health Commission and the State Drug Administration are actively working on the issue and created an inoculation plan for patients who have injected rabies vaccines from the Changchun Changsheng company. And the patients who are getting treated and those whose required course are not yet completed can switch to vaccines from other companies at no charge.

China government also start giving free re-inoculated who have completed their courses less than a year ago and vaccination institutions will provide tracking, observation, and advisory services.

Related Posts

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

The rise in raw material costs cannot immediately be passed on to patients as prices of many medicines in India are regulated by the National Pharmaceutical Pricing Authority. The ongoing…

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

New Delhi: The state governments of Maharashtra, Gujarat, and Uttarakhand are the front runners in taking action against the complaints they received on misleading and objectionable advertisements related to Ayush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

Sakeena Itoo reviews performance, functioning of JKMSCL

Sakeena Itoo reviews performance, functioning of JKMSCL

Dr Arun Prasad gets Recognition in London for Global Impact

Dr Arun Prasad gets Recognition in London for Global Impact

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

NSQ reporting nearly doubles in 2025, buoyed by greater state participation